UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 778

Sortiert nach

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4274-4282

2020

Volltextzugriff (PDF)

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival

Journal of clinical oncology, 2016-09, Vol.34 (27), p.3308-3314

2016

Volltextzugriff (PDF)

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

Nature communications, 2022-05, Vol.13 (1), p.3022-17, Article 3022

2022

Volltextzugriff (PDF)

Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer

Clinical cancer research, 2020-06, Vol.26 (11), p.2556-2564

2020

Volltextzugriff (PDF)

Metaplastic Carcinoma of the Breast is More Aggressive than Triple-Negative Breast Cancer: A study from a Single Institution and Review of Literature

Clinical breast cancer, 2017-08, Vol.17 (5), p.382-391

2017

Volltextzugriff (PDF)

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network

Cancer, 2012-11, Vol.118 (22), p.5463-5472

2012

Volltextzugriff (PDF)

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Journal of clinical oncology, 2022-08, Vol.40 (22), p.2408-2419

2022

Volltextzugriff (PDF)

Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

JAMA oncology, 2022-08, Vol.8 (8), p.1177

2022

Volltextzugriff (PDF)

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2254-2261

2015

Volltextzugriff (PDF)

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

Clinical cancer research, 2020-06, Vol.26 (11), p.2565-2572

2020

Volltextzugriff (PDF)

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer

Journal of clinical oncology, 2018-02, Vol.36 (6), p.543-553

2018

Volltextzugriff (PDF)

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience

Journal of clinical oncology, 2015-02, Vol.33 (4), p.340-348

2015

Volltextzugriff (PDF)

Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study

Journal of clinical oncology, 2014-07, Vol.32 (20), p.2142-2150

2014

Volltextzugriff (PDF)

Subtype switching in breast cancer brain metastases: a multicenter analysis

Neuro-oncology (Charlottesville, Va.), 2020-08, Vol.22 (8), p.1173-1181

2020

Volltextzugriff (PDF)

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.622-630

2015

Volltextzugriff (PDF)

A Computer-Based Graphic Organizer With Embedded Self-Regulated Learning Strategies to Support Student Writing

Intervention in school and clinic, 2019-09, Vol.55 (1), p.13-22

2019

Volltextzugriff (PDF)

Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

Nature communications, 2024-03, Vol.15 (1), p.2446-19, Article 2446

2024

Volltextzugriff (PDF)

Student preconceptions of sex differences in animal behaviour classes: observations, recommendations and need for research

Animal behaviour, 2022-10, Vol.192, p.95-100

Hughes, Melissa

2022

Volltextzugriff (PDF)

Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

Nature communications, 2023-12, Vol.14 (1), p.8321-8321, Article 8321

2023

Volltextzugriff (PDF)

Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer

European journal of cancer (1990), 2024-04, Vol.201, p.113920-113920, Article 113920

2024

Volltextzugriff (PDF)

940-P: Personalized Diabetes Care Reduces Distress and Improves Treatment Satisfaction in Patients with Breast Cancer

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer

Journal of clinical oncology, 2012-06, Vol.30 (18), p.2218-2226

2012

Volltextzugriff (PDF)

Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade

The oncologist (Dayton, Ohio), 2019-07, Vol.24 (7), p.e441-e449

2019

Volltextzugriff (PDF)

Six decades of change in pollution and benthic invertebrate biodiversity in a southern New England estuary

Marine pollution bulletin, 2018-08, Vol.133, p.77-87

2018

Volltextzugriff (PDF)

1 – 25 von 778

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(707)
Mit Volltextzugriff
(709)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(500)
Life Sciences & Biomedicine
(443)
Humans
(298)
Female
(195)
Male
(138)
Adult
(107)
Middle Aged
(98)
Aged
(89)
Oncology
(82)
Animals
(75)
Biological And Medical Sciences
(75)
Social Sciences
(72)
Psychology
(50)
Aged, 80 And Over
(44)
Child
(44)
General & Internal Medicine
(44)
Medical Sciences
(43)
Adolescent
(42)
Multidisciplinary Sciences
(40)
Science & Technology - Other Topics
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer

Metaplastic Carcinoma of the Breast is More Aggressive than Triple-Negative Breast Cancer: A study from a Single Institution and Review of Literature

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience

Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study

Subtype switching in breast cancer brain metastases: a multicenter analysis

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database

A Computer-Based Graphic Organizer With Embedded Self-Regulated Learning Strategies to Support Student Writing

Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

Student preconceptions of sex differences in animal behaviour classes: observations, recommendations and need for research

Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer

940-P: Personalized Diabetes Care Reduces Distress and Improves Treatment Satisfaction in Patients with Breast Cancer

Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer

Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade

Six decades of change in pollution and benthic invertebrate biodiversity in a southern New England estuary

Suchergebnisse filtern